Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Nov;34(4):245-253.
doi: 10.1055/s-0040-1721760. Epub 2020 Dec 24.

Facial Transplantation: Complications, Outcomes, and Long-Term Management Strategies

Tom Shokri  1 , Robert Saadi  2 , Weitao Wang  1 , Likith Reddy  3 , Yadranko Ducic  1
Affiliations
Review

Facial Transplantation: Complications, Outcomes, and Long-Term Management Strategies

Tom Shokri et al. Semin Plast Surg. 2020 Nov.

Abstract

Within the past two decades, vascularized facial composite allotransplantation has evolved into a viable option in the reconstructive surgeons' armamentarium for patients with extensive facial disfigurements. As it has expanded the frontiers of microsurgical reconstructive techniques, facial transplantation has come to garner widespread interest within both the medical community and the general public. The procedure has established itself as an amalgamation of the forefronts of reconstructive microsurgery, immunology, and transplantation science. Therein too lies its complexity as multifaceted scientific developments are met with ethical and social issues. Both patients and physicians are faced with the everlasting challenges of immunosuppression regimens and their inherent complications, long-term aesthetic and functional considerations, the role of revision procedures, and the inevitable psychosocial implications. This article reflects on the medical and surgical advancements in facial transplantation surgery and highlights anticipated future challenges. It aims to encourage discussion regarding anticipated barriers to current practice and suggest future directions as we transition into the next phase of facial allograft transplantation.

Keywords: composite tissue allotransplantation; ethics; facial transplantation; immunosuppression; microvascular surgery.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest None declared.

Figures

Fig. 1
Fig. 1
Left: recipient eyelid tissue prior to face transplantation. Middle: eyelid in procured facial allograft with subsequent tarsorrhaphy of the superior and inferior tarsal plates. Right: allograft following inset to recipient. (Reproduced with permission of Grigos et al. 42 )
Fig. 2
Fig. 2
( A ) Progression of face vascularized composite allografts for up to an 8-year interval showing changes associated with chronic rejection. ( B ) White patches on allograft with permanent telangiectasias in one of the face vascularized composite allograft recipients: physical manifestations of chronic rejection. (Reproduced with permission of Krezdorn et al. 69 )
See this image and copyright information in PMC

References

    1. Hettiaratchy S, Butler P E.Face transplantation--fantasy or the future? Lancet 2002360(9326):5–6. - PubMed
    1. Morris P J, Bradley J A, Doyal L. Facial transplantation: a working party report from the Royal College of Surgeons of England. Transplantation. 2004;77(03):330–338. - PubMed
    1. Siemionow M, Ozmen S, Demir Y. Prospects for facial allograft transplantation in humans. Plast Reconstr Surg. 2004;113(05):1421–1428. - PubMed
    1. Wiggins O P, Barker J H, Martinez S. On the ethics of facial transplantation research. Am J Bioeth. 2004;4(03):1–12. - PubMed
    1. Shanmugarajah K, Hettiaratchy S, Butler P E. Facial transplantation. Curr Opin Otolaryngol Head Neck Surg. 2012;20(04):291–297. - PubMed